Search

everythinglearnresearchcommunity

for

Search:↓

Hair transplantation for Frontal Fibrosing Alopecia may work if done after the disease is inactive for 2 years and with ongoing treatment after surgery.

Primary idiopathic pseudopelade of Brocq causes gradual, scarring hair loss with no effective treatment.

Hair transplant surgery may cause alopecia areata, a new possible complication.

The paper concludes that recognizing bitemporal alopecia areata is important for early treatment and preventing its progression.

Alopecia areata is an autoimmune disease with genetic links, treatable with certain medications, and can affect mental health.

Frontal fibrosing alopecia causes hairline recession and eyebrow loss in postmenopausal women.

Cicatricial alopecia causes permanent hair loss and is treated to relieve symptoms and stop progression.

PRP shows promise for treating mild alopecia areata but needs more research for cicatricial alopecias.

Hair loss in women may have multiple causes, and eyebrow regrowth possible with specific injections.

Some treatments can help with a hair loss condition called alopecia areata, but none ensure lasting results; choices depend on the person, with JAK inhibitors showing promise for severe cases.

The treatment helped reduce symptoms and stabilize the hairline in most patients with Frontal Fibrosing Alopecia, but hair regrowth was limited.

Two people had unusual ring-shaped hair loss due to an autoimmune disorder.

Sudden, unusual hair loss may indicate serious underlying health issues.

The combined treatment helps improve severe hair loss and reduces the need for other medications.

The guidelines suggest using various treatments, including antidepressants and steroids, for alopecia areata and discuss the condition's genetic and immune aspects.

Early-stage Alopecia Areata was effectively treated in less than six months.

Using lidocaine before keloid injections makes the treatment more comfortable for patients.

Most patients improved with oral antibiotics, but some needed long-term treatment or had minimal response.

The combination therapy effectively improved acne keloidalis nuchae.

Alopecia areata was most common in people in their 30s and 40s, with some family history and a higher relapse rate, and larger bald areas responded better to specific immunotherapy.

A man's skin condition, pemphigus vulgaris, came back after he was treated with interleukin 2 for cancer.

Alopecia areata may be caused by the immune system attacking hair follicles.

Minoxidil injections can speed up hair regrowth in non-severe patchy hair loss, but combining it with steroids doesn't improve results.

A woman developed alopecia after her second Pfizer vaccine but regrew her hair with treatment and had no issues after a booster shot.

The Polish Society of Dermatology recommends treatments for alopecia areata that vary by severity, including topical and systemic medications, with long-term maintenance important for management.

COVID-19 may worsen hair loss in people with a certain type of scarring alopecia, but early treatment can help improve symptoms and hair regrowth.

Combining triamcinolone acetonide and immunotherapy can help regrow hair in some alopecia totalis patients.

Combining triamcinolone acetonide with immunotherapy can help regrow hair in some alopecia totalis patients.

Intralesional triamcinolone is the most effective treatment for alopecia areata, followed by excimer light therapy, and then topical minoxidil. The scalp responds better to treatment than the beard area.

Intralesional triamcinolone effectively reduces pain and inflammation in hidradenitis suppurativa flares.